Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony–Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells Journal:Biology of Blood and Marrow Transplantation | 2017 | ||
Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution Journal:Bone Marrow Transplantation | 2020 | ||
Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion Journal:Transplant Infectious Disease | 2018 |